跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVIPIL 250 FILM COATED TABLETS 250MG - HSA Drug Approval Details
Approvals
/
HSA
/
LEVIPIL 250 FILM COATED TABLETS 250MG
Approved
THERAPEUTIC
LEVIPIL 250 FILM COATED TABLETS 250MG
SUN PHARMA LABORATORIES LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Apr 12, 2019
Approval ID
3ab3d999d229b83a
Company
SUN PHARMA LABORATORIES LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
3ab3d999d229b83a
Drug Name
LEVIPIL 250 FILM COATED TABLETS 250MG
Product Name
LEVIPIL 250 FILM COATED TABLETS 250MG
Approval Number
SIN15665P
Approval Date
2019-04-12
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
N03AX14
Atc Item Name
levetiracetam
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
Levetiracetam
250mg
LEVETIRACETAM
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 12, 2019
Approval ID
3ab3d999d229b83a
Type
Therapeutic
Back to HSA Approvals